Optic Neuritis
Inflammation of the optic nerve. Commonly associated conditions include autoimmune disorders such as MULTIPLE SCLEROSIS, infections, and granulomatous diseases. Clinical features include retro-orbital pain that is aggravated by eye movement, loss of color vision, and contrast sensitivity that may progress to severe visual loss, an afferent pupillary defect (Marcus-Gunn pupil), and in some instances optic disc hyperemia and swelling. Inflammation may occur in the portion of the nerve within the globe (neuropapillitis or anterior optic neuritis) or the portion behind the globe (retrobulbar neuritis or posterior optic neuritis).
Subtype terms (1)
More specific conditions that are subtypes of Optic Neuritis in the MeSH hierarchy.
- Neuromyelitis Optica
65 drugs (35 approved, 30 experimental)
Drugs by status
Approved for this indication (3)
Phase 4 trials (3)
Phase 3 trials (5)
Phase 1 trials (4)
Other trials (2)
Organizations
Organization Involved with Phase 4 Indications (7)
Organization Involved with Phase 3 Indications (14)
- Acorda Therapeutics
- Teva
- National Eye Institute (NEI)
- Johns Hopkins University
- University of Copenhagen
- University of Freiburg
- MedDay Pharmaceuticals
- Hopital Maison Blanche
- Roosevelt Hospital
- Humboldt University
- Washington University in St. Louis
- NeuroCure Clinical Research Center
- German Federal Ministry of Education and Research
- Alpharma
Organization Involved with Phase 2 Indications (18)
- Merck Serono
- Merck KGaA
- Novartis
- University of London
- Guangxi Medical University
- Hacettepe University
- University of Sydney
- Saarland University
- University of Calgary
- University of California, San Francisco
- University of Vienna
- Isfahan University
- University of Oxford
- University of Goettingen
- National Multiple Sclerosis Society
- Multiple Sclerosis Society of Great Britain and Northern Ireland
- Neuroscience Canada
- Clene Nanomedicine
Organization Involved with Phase 1 Indications (5)
Organization Involved with Other Experimental Indications (4)